Aminologics Co.Ltd (074430) - Total Liabilities
Based on the latest financial reports, Aminologics Co.Ltd (074430) has total liabilities worth ₩30.52 Billion KRW (≈ $20.68 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Aminologics Co.Ltd (074430) equity growth momentum to track the company's year-over-year net asset growth rate.
Aminologics Co.Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Aminologics Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See Aminologics Co.Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Aminologics Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Aminologics Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Skane mollan AB
ST:SKMO
|
Sweden | Skr35.70 Million |
|
Mirae Asset Daewoo Co Ltd
KO:006805
|
Korea | ₩136.81 Trillion |
|
U&I Corporation
KQ:056090
|
Korea | ₩31.20 Billion |
|
Rayence Co. Ltd
KQ:228850
|
Korea | ₩23.85 Billion |
|
Akin Tekstil AS
IS:ATEKS
|
Turkey | TL1.71 Billion |
|
Evertex Fabrinology Ltd
TW:1470
|
Taiwan | NT$196.08 Million |
|
CENIT Aktiengesellschaft
XETRA:CSH
|
Germany | €112.46 Million |
|
Cintac
SN:CINTAC
|
Chile | CL$448.56 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Aminologics Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Aminologics Co.Ltd (074430) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aminologics Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aminologics Co.Ltd (2008–2025)
The table below shows the annual total liabilities of Aminologics Co.Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩28.18 Billion ≈ $19.10 Million |
+453.31% |
| 2024-12-31 | ₩5.09 Billion ≈ $3.45 Million |
+56.39% |
| 2023-12-31 | ₩3.26 Billion ≈ $2.21 Million |
-22.04% |
| 2022-12-31 | ₩4.18 Billion ≈ $2.83 Million |
-28.57% |
| 2021-12-31 | ₩5.85 Billion ≈ $3.96 Million |
-10.98% |
| 2020-12-31 | ₩6.57 Billion ≈ $4.45 Million |
+10.95% |
| 2019-12-31 | ₩5.92 Billion ≈ $4.01 Million |
+61.32% |
| 2018-12-31 | ₩3.67 Billion ≈ $2.49 Million |
-13.19% |
| 2017-12-31 | ₩4.23 Billion ≈ $2.87 Million |
-5.56% |
| 2016-12-31 | ₩4.48 Billion ≈ $3.03 Million |
-33.68% |
| 2015-12-31 | ₩6.75 Billion ≈ $4.58 Million |
-0.47% |
| 2014-12-31 | ₩6.78 Billion ≈ $4.60 Million |
-12.81% |
| 2013-12-31 | ₩7.78 Billion ≈ $5.27 Million |
-63.30% |
| 2012-12-31 | ₩21.20 Billion ≈ $14.37 Million |
-7.42% |
| 2011-12-31 | ₩22.90 Billion ≈ $15.52 Million |
-3.59% |
| 2010-12-31 | ₩23.75 Billion ≈ $16.09 Million |
+72.46% |
| 2008-12-31 | ₩13.77 Billion ≈ $9.33 Million |
-- |
About Aminologics Co.Ltd
Aminologics Co.,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. Its products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, 4-chloro-D-phenylalanine, 3-(2-napthyl)-L-alanine, R-beta-phenylalanine, D… Read more